Form 4: Prestige Consumer Healthcare Executive Stock Transaction

EVP of Marketing & Sales Adel Mekhail reported the vesting of performance stock units and acquisition of restricted stock in Prestige Consumer Healthcare.

Summary

• Adel Mekhail, EVP of Marketing & Sales, acquired 3,505 shares of common stock through the settlement of performance stock units (PSUs) on May 4, 2026.
• 1,695 shares were withheld by the company at a price of $55.31 per share to satisfy tax obligations related to the vesting.
• The reporting person was granted 4,014 shares of restricted stock.
• Following these transactions, the reporting person holds a total of 26,190 shares of common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral administrative filing reflecting routine executive compensation and equity management.

Positives

• The vesting of performance stock units indicates the achievement of specific per-share growth goals set in 2023.
• The executive maintains a significant equity stake of 26,190 shares, aligning interests with shareholders.

Negatives

• The transaction involved a tax-related sell-to-cover of 1,695 shares, which is a standard administrative procedure but reduces the net share increase.

Risks

• Future vesting of the 4,014 restricted stock units is subject to continued employment and time-based vesting schedules through 2029.

Future Outlook

The executive holds 4,014 restricted stock units that will vest in three equal annual installments starting May 4, 2027, contingent on continued service.

Industry Context

StockSavvy.ai notes that this filing reflects standard executive compensation practices within the consumer healthcare sector, where performance-based equity is used to incentivize long-term growth and retention.

Comparison to Industry Standards

• The use of performance stock units (PSUs) tied to per-share growth is consistent with compensation structures at peer companies like Church & Dwight and Perrigo.
• The tax-withholding mechanism is a standard industry practice for equity-based compensation.

Stakeholder Impact

• Minimal impact on shareholders as this is a routine equity compensation event.

Next Steps

• Vesting of restricted stock installments on May 4, 2027, May 4, 2028, and May 4, 2029.

Key Dates

Keywords

Prestige Consumer Healthcare, PBH, Insider Trading, Form 4, Executive Compensation, Equity Vesting